Bausch Health Companies (BHC) Other Operating Expenses (2009 - 2026)
Bausch Health Companies (BHC) reported Other Operating Expenses of -$32.0 million for Q1 2026, down 113.33% on a YoY basis from $240.0 million in Q1 2025, and up 50.77% sequentially from -$65.0 million in Q4 2025.
Bausch Health Companies (BHC) Other Operating Expenses (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Other Operating Expenses data on file, last reported at -$32.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Operating Expenses fell 113.33% year-over-year to -$32.0 million; the trailing twelve-month figure through Mar 2026 stood at -$159.0 million (up 39.31% YoY), and the FY2025 full-year result was -$142.0 million, up 42.51% from the prior year.
- Other Operating Expenses rose to -$32.0 million in Q1 2026, from -$65.0 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $83.0 million in Q2 2023 to a low of -$225.0 million in Q3 2024.
- A 5-year average of -$32.3 million and a median of -$23.0 million in 2023 frame the typical range for Other Operating Expenses.
- Peak annual rise in Other Operating Expenses reached 190.0% in 2025, while the deepest fall reached 3150.0% in 2025.
- Tracing BHC's Other Operating Expenses over 5 years: stood at -$29.0 million in 2022, then gained by 3.45% to -$28.0 million in 2023, then surged by 92.86% to -$2.0 million in 2024, then sank by 3150.0% to -$65.0 million in 2025, then surged by 50.77% to -$32.0 million in 2026.
- Business Quant data shows BHC's Other Operating Expenses at -$32.0 million in Q1 2026, -$65.0 million in Q4 2025, and -$80.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.00 Mn |
| Dec 31, 2025 | -65.00 Mn |
| Sep 30, 2025 | -80.00 Mn |
| Jun 30, 2025 | 18.00 Mn |
| Mar 31, 2025 | -15.00 Mn |
| Dec 31, 2024 | -2.00 Mn |
| Sep 30, 2024 | -225.00 Mn |
| Jun 30, 2024 | -20.00 Mn |
| Dec 31, 2023 | -28.00 Mn |
| Sep 30, 2023 | -60.00 Mn |
| Jun 30, 2023 | 83.00 Mn |
| Mar 31, 2023 | -23.00 Mn |
| Dec 31, 2022 | -29.00 Mn |
| Sep 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | -2.00 Mn |
| Dec 31, 2021 | -44.00 Mn |
| Sep 30, 2021 | 183.00 Mn |
| Jun 30, 2021 | -542.00 Mn |
| Mar 31, 2021 | 30.00 Mn |
| Dec 31, 2020 | -330.00 Mn |